Transarterial Treatment of Colorectal Cancer Liver Metastases with Irinotecan-Loaded Drug-Eluting Beads: Technical Recommendations |
| |
| Affiliation: | 1. Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy;2. Interventional Oncology Unit, Istituto Oncologico Veneto, Padua, Italy;3. Department of Interventional Radiology, Institut Gustav Roussy, Villejuif, France;4. Department of Radiology, Hospital Italiano, Universidad de Buenos Aires, Buenos Aires, Argentina;5. Division of Vascular Interventional Radiology, University of Miami Miller School of Medicine, Miami, Florida;6. Division of Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin;7. Division of Surgical Oncology, University of Louisville, Louisville, Kentucky;8. Department of Radiology, University Hospital Aintree, Liverpool, United Kingdom;9. Department of Radiology, Wesley Hospital, Auchenflower, Australia;1. Department of Imaging Sciences, University of Rochester Medical Center, 601 Elmwood Avenue, Box 648, Rochester, NY 14642;2. Department of Radiation Oncology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 648, Rochester, NY 14642;1. Department of Diagnostic Radiology, Hiroshima University, Hiroshima, Japan;2. Department of Gastroenterology and Metabolism, Hiroshima University, Hiroshima, Japan;3. Department of Radiology, Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital, Hiroshima, Japan;4. Department of Radiology, Hiroshima City Hospital, Hiroshima, Japan;5. Department of Radiology, Natural Hospital Organization, Kure Medical Center, Kure, Japan;1. Department of Hepatology, University Hospitals Leuven, Herestraat 49;2. Department of Radiology, University Hospitals Leuven, Herestraat 49;3. Department of Clinical and Experimental Medicine, KU Leuven, 3000 Leuven, Belgium;1. Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065;2. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065;3. Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065;4. Department of Gastrointestinal Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065;5. Weill Cornell Medical College, New York, New York;6. Department of Surgery, Division of Hepatobiliary and Pancreatic Surgery, City of Hope National Medical Center, Duarte, California.;1. Department of Medical Imaging and Radiology, National Taiwan University College of Medicine and Hospital, No. 7 Chung-Shan S. Road, Taipei, Taiwan 100;2. Department of Oncology, National Taiwan University College of Medicine and Hospital, No. 7 Chung-Shan S. Road, Taipei, Taiwan 100;3. Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, No. 7 Chung-Shan S. Road, Taipei, Taiwan 100 |
| |
| Abstract: | Transcatheter hepatic arterial administration of irinotecan-loaded drug-eluting beads (DEBIRI) is used to treat liver-only or liver-dominant metastatic disease from colorectal cancer (CRC). Eligibility for DEBIRI should be established in each individual patient by a multidisciplinary team based on comprehensive clinical, imaging, and laboratory assessment. Standardization of DEBIRI technique and protocols would be expected to lead to improved efficacy and safety. The present article provides a set of technical recommendations for the use of DEBIRI in the treatment of hepatic CRC metastases. |
| |
| Keywords: | CRC" },{" #name" :" keyword" ," $" :{" id" :" key0010" }," $$" :[{" #name" :" text" ," _" :" colorectal cancer DEBIRI" },{" #name" :" keyword" ," $" :{" id" :" key0020" }," $$" :[{" #name" :" text" ," _" :" irinotecan-loaded drug-eluting bead |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
